HomeUJJIVANSFB › Filing
🔔 Get instant alerts when UJJIVANSFB files quarterly results on BSE Start free trial →

Transcript of conference call held on September 01, 2026.

Filed: 03 Sep 2026, 11:25 IST Exchange: BSE Category: General Update — Investor/Analyst Meet
AI summary - MD & CEO Sanjeev Nautiyal took early retirement due to health issues - Executive Director Carol Furtado appointed Interim MD & CEO, pending RBI approval - FY27 guidance and growth plans remain on track despite leadership change - Q1 loan book grew ~29% y-y; GNPA at 2.2%; secured book share >50% - CASA grew 38% y-y; cost of funds at 6.9% for Q1 - New MSME Business Head Vikas Agarwal joined; no change to FY27 strategy - Board initiated expedited search for permanent MD; names to be submitted in 3-4 months - No material issues beyond health for CEO exit; succession planning to improve - No impact seen from El Nino on asset quality or growth so far
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 UJJIVANSFB — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add UJJIVANSFB to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Ujjivan Small Finance Bank Limited

Important. The summary above is generated automatically from Ujjivan Small Finance Bank Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.